An indirect immunofluorescence assay and a direct immunofluorescence assay were evaluated for typing clinical isolates of herpes simplex virus (HSV). The indirect immunofluorescence assay (Electro-Nucleonics, Inc.) correctly identified 16 HSV type 2 (HSV-2) isolates, but failed to identify 4 of 14 HSV-1 isolates because of background fluorescence and instability of reagents. Forty-nine HSV-1 isolates were correctly typed by direct immunofluorescence assay (Kallestad Laboratories, Inc.), but 1 of 39 HSV-2 isolates did not react with the HSV-2 type-specific antibody conjugate.
Typing of herpes simplex virus (HSV) by immunofluorescence with conventionally produced animal antisera is generally unreliable because of the extensive antigenic crossreactivity of HSV type 1 (HSV-1) and HSV-2 (2, 5) . Typespecific monoclonal antibodies have the potential for unambiguous differentiation of HSV-1 and HSV-2. In this study we Restriction endonuclease analysis of NaI gradient-purified viral DNA was performed as previously described (1) cleonics, Inc. (ENI), Columbia, Md. This test utilizes HSV type-common and HSV-2 type-specific monoclonal antibodies, which are used in conjunction with fluorescein isothiocyanate-conjugated goat anti-mouse antibodies in the indirect test. HSV-1 isolates react with only the type-common antibody, whereas HSV-2 strains react with both the type-common and HSV-2 type-specific antibody.
Eighty-eight isolates were typed by direct immunofluorescence with reagents provided by Kallestad Laboratories, Inc., Chaska, Minn. This test employs type-specific fluorescein isothiocyanate-conjugated monoclonal antibodies that are directed against epitopes on either HSV-1 or HSV-2.
Infected cells, harvested when 75 to 100% of the cell culture displayed a typical cytopathic effect, were pelleted by centrifugation and suspended in phosphate-buffered saline (pH 7.2) before application to the slide. Air-dried slides were fixed in acetone (-20°C) and stored at -70°C before testing. Staining was performed according to the manufacturer's instructions. Slides were examined at x400 with a Nikon Optiphot microscope with a 50-W mercury arc bulb.
Intensity of fluorescence was graded as follows: 4+, glaring-green fluorescence; 3+, bright-green fluorescence; 2+, dull-green fluorescence; 1+, very-dim-green fluorescence.
Three HSV-1 isolates and six HSV-2 isolates were correctly typed with reagents from ENI lot 8715 (Table 1) . HSV-1-infected cells fluoresced with an intensity of 3+ to 4+ with the type-common antibody. HSV-2-infected cells fluoresced with 3+ to 4+ intensity with the type-common antibody, but only 1+ to 2+ with the HSV-2 type-specific antibody. Diffuse, dim cytoplasmic fluorescence was observed with cells infected with HSV-1 clinical isolates stained (Table 2 ). These reagents gave virtually no background with either of the monoclonal antibody preparations in honmologous or heterologous infected cells. The HSV-1-specific reagent showed diffuse cytoplasmic fluorescence. Sometimes small granules were visible in addition to the diffuse fluorescence, but these were also exclusively cytoplasmic. The HSV-2 monoclonal antibody reacted with an antigen that was exclusively nuclear. The usual fluorescence pattern was relatively large granules sonletimes with stained nucleoli appearing as very large granules. The average staining intensity with both the HSV-1 and HSV-2 specific monoclonals was 3+ to 4+.
ENI has chosen to use a type-common monoclonal antibody and a HSV-2 type-specific antibody. The type-common antibody could be used in cases where one wished to simply detect HSV without actually typing a specimen or isolate. It has not yet been shown that the epitope against which this antibody is directed is more highly conserved than other viral epitopes, so it is possible that some HSV strains may not react. The background fluorescence observed with HSV-1-infected cells as well as diminished intensity of fluorescence upon storage were major undesirable factors with these reagents. Because of these problems, the ENI products were not tested further.
The direct conjugates from Kallestad Laboratories were tested more extensively. The most desirable aspects of these reagents were the virtual absence of background fluorescence and the clearly distinguishable HSV-1 and HSV-2 fluorescence patterns. These characteristics contributed to more easily read slides and enhanced the reliability and accuracy by diminishing the possibility of technical errors in staining. These reagents were also more stable and yielded essentially unchanged fluorescence after 8 weeks of storage.
The failure of one HSV-2 strain to react with the HSV-2-specific conjugate underscores the risk of using a single monoclonal antibody for typing HSV. The problem of nonreactivity of certain isolates with monoclonal antibodies has been investigated and discussed in detail by others (4, 5) .
Some epitopes are more highly conserved than others, but the genetic variability of HSV is such that one could not expect any single epitope to be absolutely conserved in ail clinical isolates. Thus an overall sensitivity of 100% is perhaps an unreachable goal with reagents employing single monoclonal antibodies.
The use of monoclonal antibodies for typing HSV isolates promises reliability comparable to that of restriction endonuclease analysis. However, problems such as background fluorescence, weak intensity of fluorescence, instability of reagents, and narrow antigenic specificity must first be addressed.
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